1	1,25-Dihydroxyvitamin	1,25-Dihydroxyvitamin	_	_	_	_	_	_	_
2	D3	D3	_	_	_	_	_	_	_
3	receptor	receptor	_	_	_	_	_	_	_
4	RNA	RNA	_	_	_	_	_	_	_
5	:	:	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	hematopoietic	hematopoietic	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	1,25-Dihydroxyvitamin	1,25-Dihydroxyvitamin	_	_	_	_	_	_	_
2	D3	D3	_	_	_	_	_	_	_
3	[	[	_	_	_	_	_	_	_
4	1,25(OH)2D3	1,25(OH)2D3	_	_	_	_	_	_	_
5	]	]	_	_	_	_	_	_	_
6	induces	induce	_	_	_	_	_	_	_
7	differentiation	differentiation	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	inhibits	inhibit	_	_	_	_	_	_	_
10	proliferation	proliferation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	myeloid	myeloid	_	_	_	_	_	_	_
13	leukemic	leukemic	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	various	various	_	_	_	_	_	_	_
17	lines	line	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	;	;	_	_	_	_	_	_	_
21	these	these	_	_	_	_	_	_	_
22	effects	effect	_	_	_	_	_	_	_
23	are	be	_	_	_	_	_	_	_
24	probably	probably	_	_	_	_	_	_	_
25	mediated	mediate	_	_	_	_	_	_	_
26	through	through	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
29	receptor	receptor	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Little	little	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	known	know	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
8	receptor	receptor	_	_	_	_	_	_	_
9	RNA	RNA	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	hematopoietic	hematopoietic	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	examined	examine	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	modulation	modulation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
11	receptor	receptor	_	_	_	_	_	_	_
12	RNA	RNA	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	various	various	_	_	_	_	_	_	_
15	proliferating	proliferate	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	nonproliferating	nonproliferating	_	_	_	_	_	_	_
18	hematopoietic	hematopoietic	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	RNA	RNA	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	detected	detect	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	various	various	_	_	_	_	_	_	_
11	kinds	kind	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	hematopoietic	hematopoietic	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	including	include	_	_	_	_	_	_	_
17	macrophages	macrophage	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	activated	activate	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	lymphocytes	lymphocyte	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	as	as	_	_	_	_	_	_	_
24	well	well	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	cell	cell	_	_	_	_	_	_	_
28	lines	line	_	_	_	_	_	_	_
29	KG-1	kg-1	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	myeloblasts	myeloblast	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	HL-60	HL-60	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	promyelocytes	promyelocyte	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	ML-3	ML-3	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	myelomonoblasts	myelomonoblast	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	U937	U937	_	_	_	_	_	_	_
45	,	,	_	_	_	_	_	_	_
46	THP-1	thp-1	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	monoblasts	monoblast	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	,	,	_	_	_	_	_	_	_
51	K562	K562	_	_	_	_	_	_	_
52	(	(	_	_	_	_	_	_	_
53	erythroblasts	erythroblast	_	_	_	_	_	_	_
54	)	)	_	_	_	_	_	_	_
55	,	,	_	_	_	_	_	_	_
56	and	and	_	_	_	_	_	_	_
57	S-LB1	s-lb1	_	_	_	_	_	_	_
58	(	(	_	_	_	_	_	_	_
59	HTLV-1-transfected	htlv-1-transfected	_	_	_	_	_	_	_
60	T	t	_	_	_	_	_	_	_
61	lymphocytes	lymphocyte	_	_	_	_	_	_	_
62	)	)	_	_	_	_	_	_	_
63	.	.	_	_	_	_	_	_	_

1	Receptor	receptor	_	_	_	_	_	_	_
2	transcripts	transcript	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	4.6	4.6	_	_	_	_	_	_	_
5	kilobases	kilobas	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	kb	kb	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	no	no	_	_	_	_	_	_	_
12	variant	variant	_	_	_	_	_	_	_
13	sizes	size	_	_	_	_	_	_	_
14	were	be	_	_	_	_	_	_	_
15	observed	observe	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	All	all	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	lines	line	_	_	_	_	_	_	_
4	examined	examine	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	this	this	_	_	_	_	_	_	_
7	group	group	_	_	_	_	_	_	_
8	also	also	_	_	_	_	_	_	_
9	expressed	express	_	_	_	_	_	_	_
10	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
11	receptors	receptor	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Most	most	_	_	_	_	_	_	_
2	B	B	_	_	_	_	_	_	_
3	lymphocyte	lymphocyte	_	_	_	_	_	_	_
4	lines	line	_	_	_	_	_	_	_
5	expressed	express	_	_	_	_	_	_	_
6	negligible	negligible	_	_	_	_	_	_	_
7	levels	level	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	RNA	RNA	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	;	;	_	_	_	_	_	_	_
15	however	however	_	_	_	_	_	_	_
16	;	;	_	_	_	_	_	_	_
17	analysis	analysis	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	lymphoid/myeloid	lymphoid/myeloid	_	_	_	_	_	_	_
21	somatic	somatic	_	_	_	_	_	_	_
22	hybrid	hybrid	_	_	_	_	_	_	_
23	suggested	suggest	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	suppression	suppression	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	expression	expression	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
30	receptor	receptor	_	_	_	_	_	_	_
31	RNA	RNA	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	B	B	_	_	_	_	_	_	_
34	lymphocytes	lymphocyte	_	_	_	_	_	_	_
35	may	may	_	_	_	_	_	_	_
36	be	be	_	_	_	_	_	_	_
37	a	a	_	_	_	_	_	_	_
38	dominant	dominant	_	_	_	_	_	_	_
39	characteristic	characteristic	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	HL-60	HL-60	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	cultured	culture	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	10(-7)	10(-7)	_	_	_	_	_	_	_
7	mol/L	mol/l	_	_	_	_	_	_	_
8	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	24	24	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	72	72	_	_	_	_	_	_	_
13	hours	hour	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	levels	level	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
21	receptor	receptor	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	its	its	_	_	_	_	_	_	_
24	RNA	RNA	_	_	_	_	_	_	_
25	were	be	_	_	_	_	_	_	_
26	examined	examine	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Levels	level	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	RNA	RNA	_	_	_	_	_	_	_
4	coding	coding	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	receptor	receptor	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	modulated	modulate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	exposure	exposure	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	high	high	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	ligand	ligand	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Levels	level	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	occupied	occupy	_	_	_	_	_	_	_
4	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	increased	increase	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	these	these	_	_	_	_	_	_	_
10	HL-60	hl-60	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	;	;	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	total	total	_	_	_	_	_	_	_
16	number	number	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
19	receptors	receptor	_	_	_	_	_	_	_
20	decreased	decrease	_	_	_	_	_	_	_
21	about	about	_	_	_	_	_	_	_
22	50	50	_	_	_	_	_	_	_
23	%	%	_	_	_	_	_	_	_
24	at	at	_	_	_	_	_	_	_
25	24	24	_	_	_	_	_	_	_
26	hours	hour	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	returned	return	_	_	_	_	_	_	_
29	toward	toward	_	_	_	_	_	_	_
30	normal	normal	_	_	_	_	_	_	_
31	at	at	_	_	_	_	_	_	_
32	72	72	_	_	_	_	_	_	_
33	hours	hour	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Steady-state	steady-state	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	RNA	RNA	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	affected	affect	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	terminal	terminal	_	_	_	_	_	_	_
12	differentiation	differentiation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	HL-60	hl-60	_	_	_	_	_	_	_
15	toward	toward	_	_	_	_	_	_	_
16	either	either	_	_	_	_	_	_	_
17	granulocytes	granulocyte	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	macrophages	macrophage	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Nondividing	nondivide	_	_	_	_	_	_	_
2	macrophages	macrophage	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	normal	normal	_	_	_	_	_	_	_
5	individuals	individual	_	_	_	_	_	_	_
6	also	also	_	_	_	_	_	_	_
7	expressed	express	_	_	_	_	_	_	_
8	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
9	receptor	receptor	_	_	_	_	_	_	_
10	RNA	RNA	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	nondividing	nondividing	_	_	_	_	_	_	_
5	peripheral	peripheral	_	_	_	_	_	_	_
6	blood	blood	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	normal	normal	_	_	_	_	_	_	_
10	individuals	individual	_	_	_	_	_	_	_
11	did	do	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	express	express	_	_	_	_	_	_	_
14	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	RNA	RNA	_	_	_	_	_	_	_
17	;	;	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	stimulation	stimulation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	proliferation	proliferation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	these	these	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	accumulation	accumulation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
29	receptor	receptor	_	_	_	_	_	_	_
30	RNA	RNA	_	_	_	_	_	_	_
31	increased	increase	_	_	_	_	_	_	_
32	markedly	markedly	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Half-life	half-life	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	t1/2	t1/2	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
7	receptor	receptor	_	_	_	_	_	_	_
8	RNA	RNA	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	short	short	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	1	1	_	_	_	_	_	_	_
16	hour	hour	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	determined	determine	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	measuring	measure	_	_	_	_	_	_	_
22	decay	decay	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	message	message	_	_	_	_	_	_	_
26	after	after	_	_	_	_	_	_	_
27	addition	addition	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	actinomycin	actinomycin	_	_	_	_	_	_	_
30	D.	D.	_	_	_	_	_	_	_
31	Consistent	Consistent	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	this	this	_	_	_	_	_	_	_
34	short	short	_	_	_	_	_	_	_
35	t1/2	t1/2	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	accumulation	accumulation	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
40	receptor	receptor	_	_	_	_	_	_	_
41	RNA	RNA	_	_	_	_	_	_	_
42	increased	increase	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	cells	cell	_	_	_	_	_	_	_
45	as	as	_	_	_	_	_	_	_
46	their	their	_	_	_	_	_	_	_
47	protein	protein	_	_	_	_	_	_	_
48	synthesis	synthesis	_	_	_	_	_	_	_
49	was	be	_	_	_	_	_	_	_
50	inhibited	inhibit	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Further	further	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	required	require	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	understand	understand	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	physiologic	physiologic	_	_	_	_	_	_	_
9	role	role	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	1,25(OH)2D3	1,25(oh)2d3	_	_	_	_	_	_	_
12	receptors	receptor	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	myeloid	myeloid	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	proliferating	proliferate	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	lymphocytes	lymphocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

